Log In
Print
BCIQ
Print
Print this Print this
 

PxM-01

  Manage Alerts
Collapse Summary General Information
Company PhosImmune Inc.
DescriptionA cocktail of undisclosed phospeptide tumor antigens (PTAs)
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationMelanoma
Indication DetailsTreat melanoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today